Scientists track how chemotherapy affects brain tumor Patients' minds and lives
NCT ID NCT03257618
Summary
This study aimed to understand how a chemotherapy drug called temozolomide (TMZ) affects the thinking skills and quality of life of adults with a specific slow-growing brain tumor (diffuse low-grade glioma). Researchers followed 26 patients over a year to measure changes in memory, attention, and daily well-being. The goal was to gather better information to help preserve patients' quality of life since there is no cure for this tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut regional du Cancer - Val d Aurelle
Montpellier, 34298, France
Conditions
Explore the condition pages connected to this study.